$49 per month*
.
Subscribe to Pro or Enterprise plans to unlock this feature.
Subscribe to Pro or Enterprise plans to unlock this feature.
Become a smarter investor today.
Become a smarter investor today.
This statistic highlights Amyris Inc’s Revenue Breakdown Worldwide, split between Asia, Brazil, Europe and North America, reported on a quarterly basis from Q1 2018 onwards.
Amyris Inc’s Revenue Breakdown Worldwide
Region | 2022 Q1 | 2022 Q4 | 2023 Q1 | YoY Growth (2023 Q1) |
Asia | 1,680,000.0 | 8,549,000.0 | 2,527,000.0 | 50.42% |
Brazil | 1,019,000.0 | 1,741,000.0 | 1,878,000.0 | 84.30% |
Europe | 19,432,000.0 | 4,196,000.0 | 3,700,000.0 | -80.96% |
North America | 34,865,000.0 | 60,595,000.0 | 47,502,000.0 | 36.25% |
Other | 713,000.0 | 721,000.0 | 476,000.0 | -33.24% |
(All the figures are in USD, except percentages)
Amyris Inc, a worldwide biotechnology corporation, operates in several locations, providing innovative solutions generated from renewable resources. We obtain significant insights into Amyris’ geographical performance and the dynamics of its revenue streams by studying revenue data for Asia, Brazil, Europe, North America, and Other areas during the first quarters of 2022, fourth quarters of 2022, and first quarters of 2023.
Asia
During the investigated periods, the data show a significant revenue increase in the Asia area. Starting at 1,680,000.0 USD in 2022 Q1, sales climbed substantially to 8,549,000.0 USD in 2022 Q4, representing a 409.23% rise. The first quarter of 2023 witnessed a decrease to 2,527,000.0 USD, but it still represented a remarkable year-on-year gain of 50.42%. The timing of significant contracts or project milestones might explain the swings in revenue in this region.
Brazil
Amyris Inc’s Brazil area likewise had significant growth over the examined periods. The revenue began at 1,019,000.0 USD in 2022 Q1 and climbed to 1,741,000.0 USD in 2022 Q4, representing a 70.89% increase. The first quarter of 2023 saw more increase to 1,878,000.0 USD, representing an outstanding 84.30% year-on-year growth. The company’s focus on conquering new markets and capitalizing on Brazil’s rising interest in sustainable solutions may be linked to the company’s development in this area.
Europe
The data shows a significant drop in revenue for Amyris Inc’s Europe area during the studied periods. Starting at 19,432,000.0 USD in 2022 Q1, sales dropped dramatically to 4,196,000.0 USD in 2022 Q4, representing a -78.43% drop. The first quarter of 2023 showed a little recovery to 3,700,000 USD, but it still represented a significant -80.96% year-on-year loss. Variations in revenue in this region may be ascribed to unique variables such as market dynamics or variations in client demand.
North America
Amyris Inc’s North America area saw rapid revenue growth over the studied periods. The revenue began at 34,865,000.0 USD in 2022 Q1 and climbed to 60,595,000.0 USD in 2022 Q4, representing a 73.49% increase. The first quarter of 2023 saw a tiny decrease to 47,502,000.0 USD, resulting in a still significant year-on-year gain of 36.25%. Customers in the region appreciated the company’s strategic focus on the North American market and concentration on sustainability.
Other
During the examined periods, Amyris Inc’s revenue in the Other area fluctuated. Beginning with 713,000.0 USD in 2022 Q1, revenue climbed marginally to 721,000.0 USD in 2022 Q4, representing a 1.12% rise. However, in the first quarter of 2023, the figure fell to 476,000.0 USD, representing a -33.24% year-on-year drop. peculiar projects or market dynamics peculiar to the region may have an impact on revenue in this region.
About the Company
Amyris Inc, located in Emeryville, California, is a major biotechnology business. Amyris uses its superior synthetic biology technology to create high-performance, renewable components and compounds with a particular focus on sustainability. Cosmetics, skincare, flavors, perfumes, and other applications benefit from the company’s creative solutions. Amyris is dedicated to tackling global issues including climate change and resource depletion by creating sustainable alternatives to standard components. Amyris’ cutting-edge biotechnology seeks to have a good influence on the planet by providing eco-friendly, cost-effective, and sustainable solutions to industries throughout the world.
Did you like Amyris Inc’s Revenue Breakdown Worldwide statistic?
Access more such KPI data points and segment financials on thousands of US stocks, with Business Quant.
You can get started here.
Always know what you’ll pay. No hidden costs or surprises.
* Billed annually, local taxes extra.
* Local taxes extra.
.